Lv01
0 积分 2026-03-29 加入
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
9小时前
待确认
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
13小时前
已完结
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target
21天前
已完结
CAR T cells produced in vivo to treat cardiac injury
29天前
已完结
In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy
2个月前
已完结
皖公网安备34019202002308
